Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity
Crossref DOI link: https://doi.org/10.1007/s10585-018-9949-z
Published Online: 2019-01-04
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lai, Shiue-Wei
Bamodu, Oluwaseun Adebayo
Tsai, Wen-Chiuan
Chang, Yi-Ming
Lee, Wei-Hwa
Yeh, Chi-Tai http://orcid.org/0000-0001-5189-9755
Chao, Tsu-Yi
Text and Data Mining valid from 2019-01-04
Article History
First Online: 4 January 2019